| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |